Uriexo is a clinically proven non-antibiotic option for UTI prevention. Only uriexo double action is specially formulated with two clinically proven active ingredients at their therapeutic doses (2000 mg of d-mannose and 36 mg of pacs in its daily recommended Dose) that have been demonstrated to be effective as prophylactic therapy for patients with recurrent urinary tract infections (UTIs). when uriexo makes its way into the urinary tract, its two active ingredients (dmannose and pacs) target E. Coli at two separate anchoring sites called "pili". E. Coli account for 90 % of UTIs and may have either the type I "pili" Or type p "pili" Or both on their surface and depending on which type of "pili" They have, they may cause infection in different parts of the urinary tract. Uriexo is different in that it targets and binds to both of these "pili" Anchoring sites. This means that uriexo attracts and binds with more types of E. Coli so that the infection can be occupied and safely rinsed.